Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death

Human Molecular Genetics

Volumn 18, Issue 4, 2009, Pages 701-713

  Zheng, Ming ^a,b   Cheng, Hongqiang ^a   Li, Xiaodong ^a   Zhang, Jianlin ^a   Cui, Li ^a   Ouyang, Kunfu ^a   Han, Liang ^b   Zhao, Ting ^b   Gu, Yusu ^a   Dalton, Nancy D ^a   Bang, Marie Louise ^c,d   Peterson, Kirk L ^a   Chen, Ju ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b PEKING UNIVERSITY   (China)

^c CNR   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYPHER; CYTOSKELETON PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CARDIOMYOCYTE ULTRASTRUCTURE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEATH; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE LOSS; GENE MUTATION; HEART FUNCTION; HYPERTROPIC CARDIOMYOPATHY; LIGAND BINDING; MALE; MOUSE; MYOCARDIAL DISEASE; NONHUMAN; PREMATURE DEATH; PRIORITY JOURNAL; ULTRASTRUCTURE;

ANIMALS; CARDIOMYOPATHY, DILATED; CARRIER PROTEINS; CELL LINE; DISEASE MODELS, ANIMAL; HEART; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; MORTALITY; MUSCLE PROTEINS; MUTATION; MYOCARDIUM; PROTEIN BINDING;

MUS;

EID: 58949087565     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn400     Document Type: Article

References (53)

1. Ortiz-Lopez, R., Li, H., Su, J., Goytia, V. and Towbin, J.A. (1997) Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation, 5, 2434-2440.
2. Olson, T.M., Illenberger, S., Kishimoto, N.Y., Huttelmaier, S., Keating, M.T. and Jockusch, B.M. (2002) Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation, 105, 431-437.
3. Li, D., Tapscoft, T., Gonzalez, O., Burch, P.E., Quiñones, M.A., Zoghbi, W.A., Hill, R., Bachinski, L.L., Mann, D.L. and Roberts, R. (1999) Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation, 100, 461-464.
4. Gerull, B., Gramlich, M., Atherton, J., McNabb, M., Trombitás, K., Sasse-Klaassen, S., Seidman, J.G., Seidman, C., Granzier, H., Labeit, S. et al. (2002) Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat. Genet., 30 201-204.
5. Olson, T.M., Michels, V.V., Thibodeau, S.N., Tai, Y.S. and Keating, M.T. (1998) Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science, 280, 750-752.
6. Villard, E., Duboscq-Bidot, L., Charron, P., Benaiche, A., Conraads, V., Sylvius, N. and Komajda, M. (2005) Mutation screening in dilated cardiomyopathy: Prominent role of the beta myosin heavy chain gene. Eur. Heart J., 26, 794-803.
7. Morimoto, S., Lu, Q.W., Harada, K., Takahashi-Yanaga, F., Minakami, R., Ohta, M., Sasaguri, T. and Ohtsuki, I. (2002) Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc. Natl Acad. Sci. USA, 99, 913-918.
8. Knöll, R., Hoshijima, M., Hoffman, H.M., Person, V., Lorenzen-Schmidt, I., Bang, M.L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W. et al. (2002) The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell, 111, 943-955.
9. Kamisago, M., Sharma, S.D., DePalma, S.R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M.P., Woolf, P.K., Wigle, E.D. et al. (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N. Engl. J. Med., 343, 1688-1696.
10. Robinson, P., Mirza, M., Knott, A., Abdulrazzak, H., Willott, R., Marston, S., Watkins, H. and Redwood, C. (2002) Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J. Biol. Chem., 277, 40710-40716.
11. Chen, J. and Chien, K.R. (1999) Complexity in simplicity: Monogenic disorders and complex cardiomyopathies. J. Clin. Invest., 103 1483-1485.
12. Seidman, J.G. and Seidman, C. (2001) The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell, 104, 557-567.
13. Towbin, J.A. and Bowles, N.E. (2006) Dilated cardiomyopathy: A tale of cytoskeletal proteins and beyond. J. Cardiovasc. Electrophysiol., 17, 919-926.
14. Lapidos, K.A., Kakkar, R. and McNally, E.M. (2004) The dystrophin glycoprotein complex: Signaling strength and integrity for the sarcolemma. Circ. Res., 94, 1023-1031.
15. Dellefave, L. and McNally, E.M. (2008) Sarcomere mutations in cardiomyopathy, noncompaction, and the developing heart. Circulation 117, 2847-2849.
16. Zhou, Q., Ruiz-Lozano, P., Martone, M.E. and Chen, J. (1999) Cypher, a striated muscle-restricted PDZ and LIM domain-containing protein, binds to alpha-actinin-2 and protein kinase C. J. Biol. Chem., 274 19807-19813.
17. Zhou, Q., Chu, P.H., Huang, C., Cheng, C.F., Martone, M.E., Knoll, G., Shelton, G.D., Evans, S. and Chen, J. (2001) Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J. Cell. Biol., 155, 605-612.
18. Vatta, M., Mohapatra, B., Jimenez, S., Sanchez, X., Faulkner, G., Perles, Z., Sinagra, G., Lin, J.H., Vu, T.M., Zhou, Q. et al. (2003) Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J. Am. Coll. Cardiol., 42 2014-2027.
19. Xing, Y., Ichida, F., Matsuoka, T., Isobe, T., Ikemoto, Y., Higaki, T., Tsuji, T., Haneda, N., Kuwabara, A., Chen, R. et al. (2006) Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol. Genet. Metab., 88, 71-77.
20. Arimura, T., Hayashi, T., Terada, H., Lee, S.Y., Zhou, Q., Takahashi, M., Ueda, K., Nouchi, T., Hohda, S., Shibutani, M. et al. (2004) A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J. Biol. Chem., 279, 6746-6752.
21. Theis, J.L., Bos, J.M., Bartleson, V.B., Will, M.L., Binder, J., Vatta, M., Towbin, J.A., Gersh, B.J., Ommen, S.R. and Ackerman, M.J. (2006) Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun., 351, 896-902.
22. Sheikh, F., Bang, M.L., Lange, S. and Chen, J. (2007) 'Z'eroing in on the role of Cypher in striated muscle function, signaling, and human disease. Trends Cardiovasc. Med., 17, 258-262.
23. Selcen, D. and Engel, A.G. (2005) Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann. Neurol., 57, 269-276.
24. Chen, J., Kubalak, S.W., Minamisawa, S., Price, R.L., Becker, K.D., Hickey, R., Ross, J.J. and Chien, K.R. (1998) Selective requirement of myosin light chain 2v in embryonic heart function. J. Biol. Chem., 273, 1252-1256.
25. Sohal, D.S., Nghiem, M., Crackower, M.A., Witt, S.A., Kimball, T.R., Tymitz, K.M., Penninger, J.M. and Molkentin, J.D. (2001) Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89, 20-25.
26. Huang, C., Zhou, Q., Liang, P., Hollander, M.S., Sheikh, F., Li, X., Greaser, M., Shelton, G.D., Evans, S. and Chen, J. (2003) Characterization and in vivo functional analysis of splice variants of Cypher. J. Biol. Chem., 278, 7360-7365.
27. Frey, N. and Olson, E.N. (2002) Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins. J. Biol. Chem., 277, 13998-14004.
28. Nourry, C., Grant, S.G. and Borg, J.P. (2003) PDZ domain proteins: Plug and play. Sci. STKE, 179, RE7.
29. Salmikangas, P., Mykkänen, O.M., Grönholm, M., Heiska, L., Kere, J. and Carpén, O. (1999) Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy. Hum. Mol. Genet., 8, 1329-1336.
30. Gontier, Y., Taivainen, A., Fontao, L., Sonnenberg, A., van der Flier, A., Carpen, O., Faulkner, G. and Borradori, L. (2005) The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins. J. Cell. Sci., 118, 3739-3749.
31. van der Ven, P.F., Wiesner, S., Salmikangas, P., Auerbach, D., Himmel, M., Kempa, S., Hayess, K., Pacholsky, D., Taivainen, A., Schröder, R. et al. (2000) Indications for a novel muscular dystrophy pathway: gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin. J. Cell. Biol., 151, 235-248.
32. Faulkner, G., Pallavicini, A., Formentin, E., Comelli, A., Ievolella, C., Trevisan, S., Bortoletto, G., Scannapieco, P., Salamon, M., Mouly, V. et al. (1999) ZASP: A new Z-band alternatively spliced PDZ-motif protein. J. Cell. Biol., 146, 465-475.
33. Hauser, M.A., Horrigan, S.K., Salmikangas, P., Torian, U.M., Viles, K.D., Dancel, R., Tim, R.W., Taivainen, A., Bartoloni, L., Gilchrist, J.M. et al. (2000) Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum. Mol. Genet., 9, 2141-2147.
34. Selcen, D. and Engel, A.G. (2004) Mutations in myotilin cause myofibrillar myopathy. Neurology, 62, 1363-1371.
35. Lehtokari, V.L., Pelin, K., Sandbacka, M., Ranta, S., Donner, K., Muntoni, F., Sewry, C., Angelini, C., Bushby, K., Van den Bergh, P. et al. (2006) Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Hum. Mutat., 27, 946-956.
36. Chang, A.N. and Potter, J.D. (2005) Sarcomeric protein mutations in dilated cardiomyopathy. Heart Fail Rev., 10, 225-235.
37. Sanger, J.M. and Sanger, J.W. (2008) The dynamic Z bands of striated muscle cells. Sci. Signal., 1, e37.
38. Moza, M., Mologni, L., Trokovic, R., Faulkner, G., Partanen, J. and Carpén, O. (2007) Targeted deletion of the muscular dystrophy gene myotilin does not perturb muscle structure or function in mice. Mol. Cell. Biol., 27, 244-252.
39. Frey, N., Barrientos, T., Shelton, J.M., Frank, D., Rütten, H., Gehring, D., Kuhn, C., Lutz, M., Rothermel, B., Bassel-Duby, R. et al. (2004) Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. Med., 10, 1336-1343.
40. Michele, D.E. and Campbell, K.P. (2003) Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem., 278, 15457-15460.
41. Solaro, R.J. (2008) Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins. J. Biol. Chem, 283, 26829-26833.
42. Ravingerová, T., Barancík, M. and Strnisková, M. (2003) Mitogen-activated protein kinases: A new therapeutic target in cardiac pathology. Mol. Cell. Biochem., 247, 127-138.
43. Hernández-Torres, F., Martínez-Fernández, S., Zuluaga, S., Nebreda, A., Porras, A., Aránega, A.E. and Navarro, F. (2008) A role for p38alpha mitogen-activated protein kinase in embryonic cardiac differentiation. FEBS Lett., 582, 1025-1031.
44. Aouadi, M., Bost, F., Caron, L., Laurent, K., Le Marchand Brustel, Y. and Binétruy, B. (2006) p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem Cells, 24, 1399-1406.
45. Petrich, B.G. and Wang, Y. (2004) Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends Cardiovasc. Med., 14, 50-55.
46. Podewski, E.K., Hilfiker-Kleiner, D., Hilfiker, A., Morawietz, H., Lichtenberg, A., Wollert, K.C. and Drexler, H. (2003) Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation, 107, 798-802.
47. Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Yamada, S., Okabe, M., Kishimoto, T. and Yamauchi-Takihara, K. (2000) Signal transductor and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin induced cardiomyopathy. Proc. Natl Acad. Sci. USA, 97, 315-319.
48. Jacoby, J.J., Kalinowski, A., Liu, M.G., Zhang, S.S., Gao, Q., Chai, G.X., Ji, L., Iwamoto, Y., Li, E., Schneider, M. et al. (2003) Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc. Natl Acad. Sci. USA, 100, 12929-12934.
49. Tsoutsman, T., Kelly, M., Ng, D.C., Tan, J.E., Tu, E., Lam, L., Bogoyevitch, M.A., Seidman, C.E., Seidman, J.G. and Semsarian, C. (2008) Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Circulation, 117 1820-1831.
50. Li, X., Zima, A.V., Sheikh, F., Blatter, L.A. and Chen, J. (2005) Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice. Circ. Res., 96, 1274-1281.
51. Zheng, M., Reynolds, C., Jo, S.H., Wersto, R., Han, Q. and Xiao, R.P. (2005) Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury. FASEB J., 19 109-111.
52. Jones, W.K., Grupp, I.L., Doetschman, T., Grupp, G., Osinska, H., Hewett, T.E., Boivin, G., Gulick, J., Ng, W.A. and Robbins, J. (1996) Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J. Clin. Invest., 98, 1906-1917.
53. Tanaka, N., Dalton, N., Mao, L., Rockman, H.A., Peterson, K.L., Gottshall, K.R., Hunter, J.J., Chien, K.R. and Ross, J., Jr (1996) Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation, 94, 1109-1117.